MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 424 SEK -0.47% Market Closed
Market Cap: 6.4B SEK
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+38%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

MCAP Price Targets Summary
MedCap AB (publ)

Wall Street analysts forecast MCAP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCAP is 554.37 SEK with a low forecast of 532.27 SEK and a high forecast of 588 SEK.

MCAP Lowest Forecast
Wall Street Target
532.27 SEK
26% Upside
MCAP Average Forecast
Wall Street Target
554.37 SEK
31% Upside
MCAP Highest Forecast
Wall Street Target
588 SEK
39% Upside
Lowest
Price Target
532.27 SEK
26% Upside
Average
Price Target
554.37 SEK
31% Upside
Highest
Price Target
588 SEK
39% Upside
MedCap AB (publ) Competitors:
Price Targets
DHR
Danaher Corp
21% Upside
TECN
Tecan Group AG
23% Upside
G
GUBRA
Gubra A/S
50% Upside
J
603127
Joinn Laboratories China Co Ltd
7% Downside
DHR
Danaher Corp
21% Upside
TECN
Tecan Group AG
23% Upside
G
GUBRA
Gubra A/S
50% Upside
J
603127
Joinn Laboratories China Co Ltd
7% Downside
CRL
Charles River Laboratories International Inc
6% Upside
BIOT
Biotage AB
3% Upside
DIVISLAB
Divi's Laboratories Ltd
7% Downside
DXRX
Diaceutics PLC
61% Upside

Revenue
Forecast

Revenue Estimate
MedCap AB (publ)

For the last 6 years the compound annual growth rate for MedCap AB (publ)'s revenue is 17%. The projected CAGR for the next 3 years is 12%.

17%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
MedCap AB (publ)

For the last 6 years the compound annual growth rate for MedCap AB (publ)'s operating income is 37%. The projected CAGR for the next 3 years is 15%.

37%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
MedCap AB (publ)

For the last 6 years the compound annual growth rate for MedCap AB (publ)'s net income is 165%. The projected CAGR for the next 3 years is 17%.

165%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

See Also

Summary
MCAP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MCAP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MCAP stock valuation using valuation multiples.
Wall Street Estimates
MCAP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MCAP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MCAP's stock price target?
Price Target
554.37 SEK

According to Wall Street analysts, the average 1-year price target for MCAP is 554.37 SEK with a low forecast of 532.27 SEK and a high forecast of 588 SEK.

What is MedCap AB (publ)'s Revenue forecast?
Projected CAGR
12%

For the last 6 years the compound annual growth rate for MedCap AB (publ)'s revenue is 17%. The projected CAGR for the next 3 years is 12%.

What is MedCap AB (publ)'s Operating Income forecast?
Projected CAGR
15%

For the last 6 years the compound annual growth rate for MedCap AB (publ)'s operating income is 37%. The projected CAGR for the next 3 years is 15%.

What is MedCap AB (publ)'s Net Income forecast?
Projected CAGR
17%

For the last 6 years the compound annual growth rate for MedCap AB (publ)'s net income is 165%. The projected CAGR for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.